EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The liver kinase B1 supports mammary epithelial morphogenesis by inhibiting critical factors that mediate epithelial‐mesenchymal transition

Kalliopi Tzavlaki, Yae Ohata, Anita Morén, Yukihide Watanabe, Jens Eriksson, Maiko Tsuchiya, Yuki Kubo, Kouhei Yamamoto, Mikael E Sellin, Mitsuyasu Kato, Laia Caja iD, Carl-Henrik Heldin und 1 weitere

Journal of Cellular Physiology · 2023

DOI: 10.1002/jcp.30975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2023. Verfasst von Kalliopi Tzavlaki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Morphogenesis, Organoids, Breast. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Magnus Bergvalls Stiftelse, Stiftelsen Lars Hiertas Minne, Vetenskapsrådet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The liver kinase B1 (LKB1) controls cellular metabolism and cell polarity across species. We previously established a mechanism for negative regulation of transforming growth factor β (TGFβ) signaling by LKB1. The impact of this mechanism in the context of epithelial polarity and morphogenesis remains unknown. After demonstrating that human mammary tissue expresses robust LKB1 protein levels, whereas invasive breast cancer exhibits significantly reduced LKB1 levels, we focused on mammary morphogenesis studies in three dimensional (3D) acinar organoids. CRISPR/Cas9‐introduced loss‐of‐function mutations of STK11 ( LKB1 ) led to profound defects in the formation of 3D organoids, resulting in amorphous outgrowth and loss of rotation of young organoids embedded in matrigel. This defect was associated with an enhanced signaling by TGFβ, including TGFβ auto‐induction and induction of transcription factors that mediate epithelial‐mesenchymal transition (EMT). Protein marker analysis confirmed a more efficient EMT response to TGFβ signaling in LKB1 knockout cells. Accordingly, chemical inhibition of the TGFβ type I receptor kinase largely restored the morphogenetic defect of LKB1 knockout cells. Similarly, chemical inhibition of the bone morphogenetic protein pathway or the TANK‐binding kinase 1, or genetic silencing of the EMT factor SNAI1, partially restored the LKB1 knockout defect. Thus, LKB1 sustains mammary epithelial morphogenesis by limiting pathways that promote EMT. The observed downregulation of LKB1 expression in breast cancer is therefore predicted to associate with enhanced EMT induced by SNAI1 and TGFβ family members.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionMorphogenesisOrganoidsBreastFemaleHumansEpithelial CellsLiverTransforming Growth Factor betaCell Line

Stichwörter der Autor:innen

bone morphogenetic protein (BMP)epithelial-mesenchymal transition (EMT)liver kinase B1 (LKB1)morphogenesistransforming growth factor β (TGFβ)

Substanzen

Transforming Growth Factor beta

Autor:innen und Institutionen

  • Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, Sweden.
  • Department of Experimental Pathology and Transborder Medical Research Center, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Department of Oral Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan.
  • Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

ORCID-Profile: Laia Caja, Aristidis Moustakas

Förderung

  • Magnus Bergvalls Stiftelse
  • Stiftelsen Lars Hiertas Minne
  • Vetenskapsrådet
  • Cancerfonden
  • H2020 European Research Council
  • Ludwig Institute for Cancer Research
  • Barncancerfonden
  • Petrus och Augusta Hedlunds Stiftelse

Zitieren

APA

Tzavlaki, K., Ohata, Y., Morén, A., Watanabe, Y., Eriksson, J., Tsuchiya, M., Kubo, Y., Yamamoto, K., Sellin, M. E., Kato, M., Caja, L., Heldin, C. H., & Moustakas, A. (2023). The liver kinase B1 supports mammary epithelial morphogenesis by inhibiting critical factors that mediate epithelial‐mesenchymal transition. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.30975

Vancouver

Tzavlaki K, Ohata Y, Morén A, Watanabe Y, Eriksson J, Tsuchiya M, et al. The liver kinase B1 supports mammary epithelial morphogenesis by inhibiting critical factors that mediate epithelial‐mesenchymal transition. Journal of Cellular Physiology. 2023. doi:10.1002/jcp.30975

BibTeX
@article{Tzavlaki2023,
  author = {Tzavlaki, Kalliopi and Ohata, Yae and Morén, Anita and Watanabe, Yukihide and Eriksson, Jens and Tsuchiya, Maiko and Kubo, Yuki and Yamamoto, Kouhei and Sellin, Mikael E and Kato, Mitsuyasu and Caja, Laia and Heldin, Carl-Henrik and Moustakas, Aristidis},
  title = {The liver kinase B1 supports mammary epithelial morphogenesis by inhibiting critical factors that mediate epithelial‐mesenchymal transition},
  journal = {Journal of Cellular Physiology},
  year = {2023},
  doi = {10.1002/jcp.30975}
}
Kostenlos starten →